Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
7K08CA001449-06
Application #
2084024
Study Section
Special Emphasis Panel (SRC (B3))
Project Start
1990-09-30
Project End
1995-08-31
Budget Start
1995-08-25
Budget End
1995-08-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
115524410
City
Boston
State
MA
Country
United States
Zip Code
02115
Lieberman, J; Fabry, J A; Fong, D M et al. (1997) Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual. AIDS Res Hum Retroviruses 13:383-92
Lieberman, J; Skolnik, P R; Parkerson 3rd, G R et al. (1997) Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood 90:2196-206
Beresford, P J; Kam, C M; Powers, J C et al. (1997) Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci U S A 94:9285-90
Roberts, C G; Meister, G E; Jesdale, B M et al. (1996) Prediction of HIV peptide epitopes by a novel algorithm. AIDS Res Hum Retroviruses 12:593-610
Buchsbaum, R J; Fabry, J A; Lieberman, J (1996) EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice. Immunol Lett 52:145-52
Srinivas, R V; Su, T; Trimble, L A et al. (1995) Enhanced susceptibility to human immunodeficiency virus infection in CD4+ T lymphocytes genetically deficient in CD43. AIDS Res Hum Retroviruses 11:1015-21
McFarland, T A; Ardman, B; Manjunath, N et al. (1995) CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis. J Immunol 154:1097-104
Lieberman, J; Fabry, J A; Shankar, P et al. (1995) Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. AIDS Res Hum Retroviruses 11:257-71
Perales, M A; Schwartz, D H; Fabry, J A et al. (1995) A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees. J Acquir Immune Defic Syndr Hum Retrovirol 10:27-35
Lacy, J; Rudnick, H (1992) Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. J Immunol 148:1554-60

Showing the most recent 10 out of 11 publications